Ramius Advisors’s Gilead Sciences GILD Stock Holding History

Ramius Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-143,778	Closed	-$9.09M	–	118
2020 Q3	$9.09M	Buy	+143,778	New	+$9.97M	2.19%	11

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ramius Advisors's GILD Position: Q4 2020 in Review

Ramius Advisors sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 143,778 shares — an estimated $9.09M sold.

Ramius Advisors first reported a position in GILD in Q3 2020 and held it in 1 quarter. The position peaked at $9.09M in Q3 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

Ramius Advisors reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
Ramius Advisors sold 143,778 Gilead Sciences shares in Q4 2020, an estimated $9.09M.
Ramius Advisors first reported a position in Gilead Sciences in Q3 2020 and held it in 1 quarter.
Ramius Advisors's Gilead Sciences position peaked at $9.09M in Q3 2020.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Ramius Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.